Immuno-oncology Board Game
In association with:
An educational board game to support health professionals involved in the management of patients who receive checkpoint inhibitor immunotherapy.
*If you already purchased a version of the physical game between 2022 - Oct 2025, you can opt to purchase an updated card pack consisting of 30 questions and 13 case studies.
PRICE = £57 plus VAT and delivery.
Visit the game website here
Add the ZeST online version to your order here
Couldn't load pickup availability
-
As the use of immunotherapy, (IO), and particularly checkpoint inhibitors, (ICIs), is increasing at an exponential rate. The ability of healthcare teams to support patients on ICIs is important. This is increasingly relevant across haemato-oncological services, including pan-tumour teams and acute oncology.
However, supporting staff to implement news ways of working is challenging. There is a need for engaging and effective educational resources, that address this subject. It focuses on the recognition, investigation and management of immune related adverse events, (irAEs), secondary to checkpoint inhibitor therapy. The game encourages players to discuss and answer a series of questions, allowing them to acquire knowledge and understanding, share ideas and learn from each other. Peer discussions are what helps players to enhance their learning.
The game will help clinicians to develop an understanding of areas including:
- What is oncological immunotherapy
- Mechanisms of IO therapy
- Types of IO therapy
- What a patient journey looks like
- Potential long-term impact of IO and associated toxicity
- Episodic nature of toxicity
- Management of toxicity and how this is evolving
- Patient perception of risk and benefit
- Short/Long term response
- Personalised medication approach
-
Game details
Teams
2 - 4
Duration
30 - 40 minutes
Contents
Board
1
Instructions
1
General Cards
1 pack
Playing pieces
4
Dice
1
- Choosing a selection results in a full page refresh.